Yesterday, I released a new version of my eBook, “Genetic Testing for Cancer – Third Edition”. We would be happy to send you one! To download a complimentary copy, please submit a request on our site here.
In 1914, the German cytologist Theodor Boveri coined the phrase “Cancer is a disease of the genome.” At this time, his ideas were as equally revolutionary as they were highly contested. Fast forward more than a hundred years later, Next-Generation Sequencing effectively permits a highly sensitive analysis of cancer cells. It can help us to understand mutations associated with cancer development and progression. It also reveals other genomic rearrangements previously unknown to occur in the cancer genome. Translation of these findings for clinical purposes is an increasing part of standard care today. Next-Generation Sequencing is rapidly becoming a powerful tool for the personalized diagnosis and management of cancer.
This third edition will show how a Tumor/Normal analysis can be conducted and how we can use Copy Number Variations (CNVs) in the diagnostics process. We also added a case study to show how VarSeq is deployed in leading institutions such as the University of Iowa.
Our special thanks go to the NIH for providing Golden Helix with exceptional funding to develop our solutions. This work is funded under the following grants: R43GM128485-01, R43GM128485-02, 2R44GM125432-01, and 2R44GM125432-02.